Total Syntheses of (+)-Chloropuupehenone and (+)-Chloropuupehenol and Their Analogues and Evaluation of Their Bioactivities

Tetracyclic pyrans (+)-chloropuupehenone (1) and (+)-chloropuupehenol (5) and its C8-R-isomer (+)-3 were synthesized via a one-pot condensation of 1-chloro-2-lithio-3,5,6-tris(tert-butyldimethylsilyloxy)benzene (8) with (4aS,8aS)-3,4,4a,5,6,7,8,8a-octahydro-2,5,5,8a-tetramethylnaphthalene-1-carboxal...

Full description

Saved in:
Bibliographic Details
Published inJournal of organic chemistry Vol. 69; no. 18; pp. 6065 - 6078
Main Authors Hua, Duy H, Huang, Xiaodong, Chen, Yi, Battina, Srinivas K, Tamura, Masafumi, Noh, Sang K, Koo, Sung I, Namatame, Ichiji, Tomoda, Hiroshi, Perchellet, Elisabeth M, Perchellet, Jean-Pierre
Format Journal Article
LanguageEnglish
Published WASHINGTON American Chemical Society 03.09.2004
Amer Chemical Soc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Tetracyclic pyrans (+)-chloropuupehenone (1) and (+)-chloropuupehenol (5) and its C8-R-isomer (+)-3 were synthesized via a one-pot condensation of 1-chloro-2-lithio-3,5,6-tris(tert-butyldimethylsilyloxy)benzene (8) with (4aS,8aS)-3,4,4a,5,6,7,8,8a-octahydro-2,5,5,8a-tetramethylnaphthalene-1-carboxaldehyde (7). The major condensation product, (4aS,6aR,12bS)-2H-9,10-bis(tert-butyldimethylsilyloxy)-11-chloro-1,3,4,4a,5,6,6a,12b-octahydro-4,4,6a,12b-tetramethyl-benzo[a]xanthene (4), after desilylation provided tetracyclic pyran (+)-(4aS,6aR,12bS)-2H-11-chloro-1,3,4,4a,5,6,6a,12b-octahydro-4,4,6a,12b-tetramethyl-benzo[a]xanthene-9,10-diol (3). At a dosage of 42 mg/rat over 8 h, pyran diol 3 inhibited the intestinal absorption of cholesterol by 71% in rats. Tetracyclic pyran 4 was also converted to o-quinone 28, which inhibited cholesteryl ester transfer protein (CETP) activity and L1210 leukemic cell viability with IC50 values of 31 and 2.4 μM, respectively. Diol (+)-5 inhibited CETP activity with an IC50 value of 16 μM. The minor condensation product, (4aS,6aS,12bS)-2H-9,10-bis(tert-butyldimethylsilyloxy)-11-chloro-1,3,4,4a,5,6,6a,12b-octahydro-4,4,6a,12b-tetramethyl-benzo[a]xanthene (6), was transformed into (+)-5 and (+)-1. A stepwise stereoselective synthesis of (+)-1 was also developed utilizing an oxyselenylation ring-closure reaction. The synthetic sequence also produced four biologically active naturally occurring drimanic sesquiterpenes, (+)-drimane-8α,11-diol (34), (−)-drimenol (38), (+)-albicanol (39), and (−)-albicanal (31) as intermediates.
Bibliography:istex:874E8E1E095F9BE20EC68C0A9D077EF2494CEE40
ark:/67375/TPS-FCR4QBJG-9
Current address:  Department of Nutritional Sciences, University of Connecticut, Storrs, CT 06269-4017.
Medline
NIH RePORTER
ISSN:0022-3263
1520-6904
DOI:10.1021/jo0491399